Sherif Rami D, Ingargiola Michael, Sanati-Mehrizy Paymon, Torina Philip J, Harmaty Marco A
Icahn School of Medicine at Mount Sinai, Department of Surgery, Division of Plastic and Reconstructive Surgery, New York, NY, USA.
Icahn School of Medicine at Mount Sinai, Department of Surgery, Division of Plastic and Reconstructive Surgery, New York, NY, USA.
J Plast Reconstr Aesthet Surg. 2017 Oct;70(10):1386-1390. doi: 10.1016/j.bjps.2017.05.023. Epub 2017 May 22.
When an implant becomes infected, implant salvage is often performed where the implant is removed, capsulectomy is performed, and a new implant is inserted. The patient is discharged with a PICC line and 6-8 weeks of intravenous (IV) antibiotics. This method has variable success and subjects the patient to long-term systemic antibiotics. In the 1960s, the use of antibiotic-impregnated beads for the treatment of chronic osteomyelitis was described. These beads deliver antibiotic directly to the site of the infection, thereby eliminating the complications of systemic IV antibiotics. This study aimed to present a case series illustrating the use of STIMULAN calcium sulfate beads loaded with vancomycin and tobramycin to increase the rate of salvage of the infected implant and forgo IV antibiotics.
A retrospective analysis was performed of patients who were treated at Mount Sinai Hospital for implant infection with salvage and antibiotic beads.
Twelve patients were identified, 10 of whom had breast cancer. Comorbidities included hypertension, smoking, and immunocompromised status. Infections were noted anywhere from 5 days to 8 years postoperatively. Salvage was successful in 9 out of the 12 infected implants using antibiotic bead therapy without home IV antibiotics.
The use of antibiotic beads is promising for salvaging infected breast implants without IV antibiotics. Seventy-five percent of the implants were successfully salvaged. Of the three patients who had unsalvageable implants, one was infected with antibiotic-resistant Rhodococcus that was refractory to bead therapy and one was noncompliant with postoperative instructions.
当植入物发生感染时,通常会进行植入物挽救手术,即取出植入物、进行包膜切除术并插入新的植入物。患者出院时会携带经外周静脉穿刺中心静脉导管(PICC)并接受6 - 8周的静脉抗生素治疗。这种方法成功率不一,且患者需接受长期的全身性抗生素治疗。在20世纪60年代,有人描述了使用抗生素浸渍珠治疗慢性骨髓炎的方法。这些珠子可将抗生素直接输送到感染部位,从而消除全身性静脉抗生素治疗的并发症。本研究旨在展示一个病例系列,说明使用负载万古霉素和妥布霉素的STIMULAN硫酸钙珠来提高感染植入物的挽救率并避免使用静脉抗生素。
对在西奈山医院接受植入物感染挽救治疗并使用抗生素珠的患者进行回顾性分析。
共确定了12例患者,其中10例患有乳腺癌。合并症包括高血压、吸烟和免疫功能低下状态。感染发生在术后5天至8年的任何时间。使用抗生素珠治疗且无需家庭静脉抗生素治疗的情况下,12个感染植入物中有9个挽救成功。
使用抗生素珠有望在不使用静脉抗生素的情况下挽救感染的乳房植入物。75%的植入物成功挽救。在3例无法挽救植入物的患者中,1例感染了对珠治疗难治的耐抗生素红球菌,1例未遵守术后医嘱。